Could licorice hold the key to treating inflammatory bowel disease?

• Licorice compound glycyrrhizin shows promise as a natural treatment for inflammatory bowel disease (IBD) in groundbreaking lab studies.
• Researchers used stem cell-derived human intestinal models to test 3,500 compounds, finding glycyrrhizin reduced inflammation and cell death.
• Traditional medicine has long used licorice for digestive and anti-inflammatory benefits, now supported by modern science.
• This discovery highlights the need for rigorous study of natural remedies as safer alternatives to pharmaceutical drugs with harsh side effects.
• Clinical trials are needed to confirm safety and efficacy in humans before glycyrrhizin can be widely recommended for IBD patients.

For millions suffering from inflammatory bowel disease (IBD), relief has often been elusive. Current treatments, ranging from anti-inflammatory drugs to immune-suppressing therapies, frequently fall short, leaving patients trapped in cycles of pain, fatigue, and digestive distress. But now, a surprising natural remedy has surfaced in the fight against this debilitating condition: glycyrrhizin, the active compound in black licorice.

Researchers at the University of Tokyo, led by Yu Takahashi, have developed a stem cell-based human intestinal model that mimics the damaging effects of IBD. By exposing lab-grown intestinal tissue to a key inflammatory protein, they recreated the disease’s destructive processes, then screened 3,500 compounds to find potential treatments. Among the most effective was glycyrrhizin, which reduced cell death in the lab model and lowered inflammation in mice with IBD.

This discovery, published in Stem Cell Reports, offers a glimmer of hope for the 4 million people worldwide battling IBD, a number that continues to rise.

A better way to test treatments

One of the biggest challenges in IBD research has been the lack of reliable lab models that accurately replicate human intestinal inflammation. Traditional animal studies and cell cultures often fail to predict how treatments will perform in people. That’s where stem cell-derived organoids (miniature, lab-grown versions of human tissue) come in.

Takahashi’s team engineered intestinal tissue from human stem cells, then triggered an IBD-like state by introducing tumor necrosis factor (TNF), a protein linked to severe inflammation in patients. The model responded just as real human intestines would, making it an ideal testing ground for potential therapies.

When they screened thousands of compounds, glycyrrhizin stood out. Not only did it protect intestinal cells from death, but it also reduced inflammation in live mice with induced colitis. Earlier studies had hinted at its benefits, but this research provides stronger evidence that glycyrrhizin could be a viable treatment option.

Why licorice? A history of healing

Glycyrrhizin isn’t new to medicine. For centuries, licorice root has been used in traditional Chinese and Ayurvedic medicine to soothe digestive issues, reduce inflammation, and even combat infections. Modern science has confirmed some of these benefits, showing that glycyrrhizin has anti-inflammatory, antioxidant, and immune-modulating properties.

Yet despite its long history of use, Western medicine has largely overlooked licorice as a serious therapeutic option… until now. The University of Tokyo’s findings suggest that this natural compound could potentially end up being just as effective as synthetic drugs, but with fewer side effects.

The bigger picture: A shift toward natural medicine?

After years of overreliance on pharmaceutical interventions, many of which come with harsh side effects, there’s growing interest in natural, evidence-based alternatives. The COVID-19 pandemic exposed deep flaws in the medical establishment’s resistance to repurposed drugs like ivermectin and hydroxychloroquine, despite their long-standing safety records. Now, as research continues to validate traditional remedies, the tide may be turning.

Glycyrrhizin’s potential aligns with a broader movement toward integrative medicine, where natural compounds are studied rigorously rather than dismissed outright. If clinical trials confirm its safety and efficacy in humans, it could become a game-changer for IBD patients who have exhausted conventional options.

What’s next? Clinical trials and caution

While the results are promising, the researchers emphasize that more studies are needed before glycyrrhizin can be recommended as a standard treatment. Clinical trials will determine the optimal dosage, long-term effects, and whether it works as well in humans as it does in lab models.

There’s also the question of side effects. High doses of licorice can cause high blood pressure, potassium loss, and hormonal imbalances in some individuals. But if used correctly, glycyrrhizin could offer a safer, more natural alternative to the immune-suppressing drugs currently prescribed for IBD.

This breakthrough underscores a critical principle in modern medicine: patients deserve access to all safe, effective treatment options—not just the ones approved by pharmaceutical giants. For too long, natural remedies have been sidelined in favor of patented drugs, even when evidence supports their use.

Hope on the horizon

For those suffering from IBD, this research is more than just a scientific curiosity; it’s a potential lifeline. If glycyrrhizin proves effective in human trials, it could provide relief where conventional medicine has failed.

One thing is clear: the future of medicine shouldn’t be limited by corporate interests or outdated dogma. It should be driven by science, transparency, and the fundamental right of patients to choose their own path to healing.

Sources for this article include:

ScienceDaily.com

SciTechDaily.com

EurekAlert.org